Olink Proteomic Research in Colorectal Cancer: Redefining Minimally Invasive Surgery through Biomarker-driven Insights
Cancer Screening and Prevention · 12.05.2026 · 000 (000) · 000-000
DOI: 10.14218/csp.2026.00029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Screening and Prevention, online erschienen am 12.05.2026. Verfasst von Zhenting Zhao und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The study by Yan and colleagues in the Journal of Proteome Research (2025) represents a valuable contribution to the emerging integration of molecular profiling in surgical oncology.1 By employing high-fidelity Olink proteomic profiling, the research provides the first plasma proteomic comparison between Endoscopic Super-Minimally Invasive Surgery (ESMIS) and laparoscopic surgery (LS) for colorectal cancer (CRC), moving beyond traditional clinical metrics to propose a data-driven framework for understanding surgical trauma and tumor biology.The identification of candidate diagnostic biomarkers (AMN, LRP1, FOXO1, PTPRJ) and surgery-specific injury markers (CALCA, PDGFC) offers tan
Zitieren
APA
Zhao, Z., Wang, N., & Zhao, P. (2026). Olink Proteomic Research in Colorectal Cancer: Redefining Minimally Invasive Surgery through Biomarker-driven Insights. Cancer Screening and Prevention, 000(000), 000-000. https://doi.org/10.14218/csp.2026.00029
Vancouver
Zhao Z, Wang N, Zhao P. Olink Proteomic Research in Colorectal Cancer: Redefining Minimally Invasive Surgery through Biomarker-driven Insights. Cancer Screening and Prevention. 2026;000(000):000-000. doi:10.14218/csp.2026.00029
BibTeX
@article{Zhao2026,
author = {Zhao, Zhenting and Wang, Nan and Zhao, Pengyue},
title = {Olink Proteomic Research in Colorectal Cancer: Redefining Minimally Invasive Surgery through Biomarker-driven Insights},
journal = {Cancer Screening and Prevention},
year = {2026},
volume = {000},
number = {000},
pages = {000--000},
doi = {10.14218/csp.2026.00029}
}
EUVIMED